Liposomal formulation of docetaxel: biodistribution and immunomodulatory benefit in HER2 breast cancer treatment - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Poster Communications Year : 2023

Liposomal formulation of docetaxel: biodistribution and immunomodulatory benefit in HER2 breast cancer treatment

Fichier principal
Vignette du fichier
SF NANO MD.pdf (1013.75 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-04356233 , version 1 (20-12-2023)

Identifiers

  • HAL Id : hal-04356233 , version 1

Cite

Mathilde Dacos, Erwann Diroff, Sarah Giacometti, Loic Osanno, Joseph Ciccolini, et al.. Liposomal formulation of docetaxel: biodistribution and immunomodulatory benefit in HER2 breast cancer treatment. SFNano 2023 Annual Meeting, Dec 2023, Montpellier, France. ⟨hal-04356233⟩
29 View
19 Download

Share

Gmail Mastodon Facebook X LinkedIn More